Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.43 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.43 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.43 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.40 |
| ▸ | PROKR1 | Q8TCW9 | 8/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PREP | P48147 | 1/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.36 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.36 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | BCR | P11274 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30009093 | 0.85 | GAA (0.38) | PLA2G7PROKR1GAANPC1HSD17B10 | |
| SCHEMBL30009435 | 0.84 | PROKR1 (0.49) | TAS1R3TAS1R1TAS1R2PROKR1GAA | |
| SCHEMBL30009418 | 0.84 | JAK1 (0.45) | PROKR1HSD17B10ABL1BCR | |
| SCHEMBL30009910 | 0.74 | JAK1 (0.40) | PLA2G7PROKR1GAANPC1HSD17B10 | |
| SCHEMBL30009325 | 0.73 | HPGD (0.66) | GAANPC1HSD17B10 | |
| SCHEMBL30009295 | 0.73 | JAK1 (0.43) | GAANPC1PREPFAP | |
| SCHEMBL34462844 | 0.72 | CHRNB2 (0.41) | TAS1R3TAS1R1TAS1R2PROKR1GAA | |
| SCHEMBL34463093 | 0.72 | HPGD (0.58) | — | |
| SCHEMBL34463038 | 0.71 | PDK2 (0.49) | TAS1R3TAS1R1TAS1R2PROKR1NPC1 | |
| SCHEMBL34462951 | 0.71 | PDK2 (0.49) | TAS1R3TAS1R1TAS1R2PROKR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524968-B2 | Heterocyclic compound as a protein kinase inhibitor | HK INNO.N CORPORATION (KR) | 2022-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524968-B2 | Heterocyclic compound as a protein kinase inhibitor | MAP3K20, MAP3K15, MAP3K1 | TAS1R3 3513/4885TAS1R1 3121/4885TAS1R2 3241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.